What is Shandong Weigao Group Medical Polymer Co Net Margin %?
Shandong Weigao Group Medical Polymer CoSHWGY 70 Net Margin % is 8.95% as of Dec. 2025, which is 49% below its 10-year median of 17.53. GuruFocus rates SHWGY with a GF Score™ of 70/100 and a GF Value™ of $3.17 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Shandong Weigao Group Medical Polymer Co ranks better than 78.21% on this metric.
SHWGY'
s Net Margin % Range Over the Past 10 Years
Min: 12.03 Med: 17.53 Max: 27.47
Current: 12.03
SHWGY's Net Margin % is ranked better than 78.21% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs SHWGY: 12.03
Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Shandong Weigao Group Medical Polymer Co Net Margin % Related Terms
Shandong Weigao Group Medical Polymer Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co Net Margin % Chart
Shandong Weigao Group Medical Polymer Co Annual Data
For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Group Medical Polymer Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co (SHWGY) has a Net Margin % of 8.95% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. This is 49% below median its historical median of 17.53. Over the past decade, Shandong Weigao Group Medical Polymer Co's Net Margin % has ranged from 12.03 to 27.47. According to the industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #178 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 21.8%.
Is Shandong Weigao Group Medical Polymer Co's Net Margin % too high?
Shandong Weigao Group Medical Polymer Co's current Net Margin % of 8.95% is 49% below median its 10-year median of 17.53. Over the past 10 years, this metric has ranged from a low of 12.03 to a high of 27.47. The Medical Devices & Instruments industry median Net Margin % is 2.07. Shandong Weigao Group Medical Polymer Co's value of 8.95% is 332.4% above this industry median. Based on the distribution chart, Shandong Weigao Group Medical Polymer Co ranks #178 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Group Medical Polymer Co ranks #178 out of 817 companies for Net Margin %. This places Shandong Weigao Group Medical Polymer Co in the top 22% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Shandong Weigao Group Medical Polymer Co's value of 8.95% is 332.4% above this benchmark. Historically, Shandong Weigao Group Medical Polymer Co's own Net Margin % has ranged from 12.03 to 27.47 over the past decade. While the company's 10-year median is 17.53 vs. the industry median of 2.07, Shandong Weigao Group Medical Polymer Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Group Medical Polymer Co's current Net Margin % of 8.95% is 332.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Group Medical Polymer Co's current Net Margin % is 8.95%, which is 49% below median its own 10-year median of 17.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.17, compared to a current price of $1.58 — trading 50.2% below its estimated fair value. The current Net Margin % is 8.95%, which is 49% below median its 10-year median of 17.53 and 332.4% above the Medical Devices & Instruments industry median of 2.07. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current Net Margin % is 8.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued.
The current stock price of $1.58 is trading 50.2% below its estimated GF Value™ of $3.17.
GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.
Key valuation signals for SHWGY:
Net Margin %: 8.95% (49% below median its 10-year median of 17.53)
GF Value™: $3.17 vs. price of $1.58 (50.2% below fair value)
Industry Position: 332.4% above the Medical Devices & Instruments median (#178 of 817)
No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Group Medical Polymer Co Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
70GF Score
Get the complete analysis for SHWGY
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHWGY has been successfully added to your 
